MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 121 filers reported holding MYOVANT SCIENCES LTD in Q4 2022. The put-call ratio across all filers is 1.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,426 | +21.3% | 90 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 90 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 90 | -35.7% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 140 | +55.6% | 0.00% | – |
| Q4 2021 | $1,000 | -95.7% | 90 | -91.0% | 0.00% | -100.0% |
| Q2 2021 | $23,000 | +9.5% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $21,000 | -25.0% | 1,000 | 0.0% | 0.01% | -28.6% |
| Q4 2020 | $28,000 | -60.0% | 1,000 | -80.0% | 0.01% | -63.2% |
| Q3 2020 | $70,000 | +600.0% | 5,000 | +900.0% | 0.02% | +533.3% |
| Q2 2020 | $10,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
| Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
| PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
| Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
| Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
| Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
| Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
| Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
| Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |